Home

Donald W. Glazer

CIK 1660940 · last filed 2024-06-07

Donald W. Glazer is a corporate insider who has filed 26 SEC Form 4 insider transactions across 1 company since 2016. The most recent filing, for BGNE, was dated Jun 7, 2024. Across all open-market trades the lifetime net is −$12.7M, making them a net seller over the disclosed history. 28 SEC filings were submitted jointly with BeiGene, Ltd.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

26

Lifetime Open-Market Net

-$12.66M

Filer Profile

Reported Address
C/O MOURANT OZANNES CORPORATE SERVICES
94 SOLARIS AVENUE
CAMANA BAY, GRAND CAYMAN, E9 KY1-1108
Related Filers
BeiGene, Ltd. — 28 joint filings, latest 2024-06-07
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BeOne Medicines Ltd. (BGNE) Delisted Director 2,756,624 $184.71 $509.18M -$12.66M 26 2024-06-07

Recent Filings

26 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-06-07 BeOne Medicines Ltd. (BGNE) Delisted Grant (A) +16,341 $0 EDGAR
2024-03-13 BeOne Medicines Ltd. (BGNE) Delisted Gift (G) −82,020 $0 EDGAR
2023-06-20 BeOne Medicines Ltd. (BGNE) Delisted Grant (A) +12,922 $0 EDGAR
2022-06-24 BeOne Medicines Ltd. (BGNE) Delisted Grant (A) +16,692 $0 EDGAR
2021-06-21 BeOne Medicines Ltd. (BGNE) Delisted Grant (A) +7,800 $0 EDGAR
2021-06-07 BeOne Medicines Ltd. (BGNE) Delisted Gift (G) −7,400 $0 EDGAR
2021-06-03 BeOne Medicines Ltd. (BGNE) Delisted Gift (G) −69,000 $0 EDGAR
2021-06-01 BeOne Medicines Ltd. (BGNE) Delisted Gift (G) −4,700 $0 EDGAR
2021-03-16 BeOne Medicines Ltd. (BGNE) Delisted Gift (G) −80,000 $0 EDGAR
2020-12-08 BeOne Medicines Ltd. (BGNE) Delisted Gift (G) −589,849 $0 EDGAR
Showing 1–10 of 26
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.